LifeMD (LFMD) Liabilities and Shareholders Equity (2012 - 2025)

LifeMD (LFMD) has reported Liabilities and Shareholders Equity for 14 consecutive years, with $70.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 7.47% year-over-year to $70.4 million; the trailing twelve-month figure through Jun 2026 stood at $136.4 million (down 53.9% YoY), and the FY2025 full-year result was $70.4 million, down 7.47% from the prior year.
• Liabilities and Shareholders Equity rose to $70.4 million in Q4 2025 per LFMD's latest filing, from $66.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $76.1 million in Q4 2024 and bottomed at $16.4 million in Q3 2021.
• Historically, Liabilities and Shareholders Equity has averaged $47.9 million across 5 years, with a median of $45.3 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Liabilities and Shareholders Equity surged 718.13% in 2021, then slumped 48.59% in 2022.
• Over 5 years, Liabilities and Shareholders Equity stood at $49.9 million in 2021, then plunged by 48.59% to $25.7 million in 2022, then soared by 127.85% to $58.5 million in 2023, then soared by 30.12% to $76.1 million in 2024, then declined by 7.47% to $70.4 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $70.4 million, $66.0 million, and $73.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.